InsidersTradesSigma
Follow the 通化东宝 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 通化东宝 has recorded 2 public disclosures. Market capitalisation: €16.4bn. The latest transaction was disclosed on 13 November 2024 (Purchase). Among the most active insiders: 王君业. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
通化东宝是一家在健康和制药领域运营的公司，在上海证券交易所上市。它专注于药物的研发和生产，特别是糖尿病治疗药物。